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Abstract 
Despite extensive experimental work, neither the 
effect of long term cryopreservation on vein graft archi -
tecture nor the failure of alloveins due to graft rejection 
have yet been investigated. Herein, we investigated ul -
trastructurally: a) the integrity of rabbit jugular veins 
following 1, 2 and 3 months of cryopreservation; b) the 
outcome of the three-month cryopreserved vein auto- and 
allografts after 1 month of implantation in the rabbit ca-
rotid artery ; and c) the immunologic response to cryo-
preserved vein allografts with and without seeded auto-
logous endothelium. Prior to implantation , the cryopre-
served rabbit veins were well-maintained except for en-
dothelial cell damage. Following implantation , the cryo-
preserved vein autografts were comparable to fresh veins 
with a complete endothelial lining. Conversely , only 
one of the allograft was still patent with features of acute 
rejection . After seeding with autologous endothelium , 
these explants failed shortly after surgery. We found 
absence of endothelium and necrosis of the media com-
ponents with neutrophil infiltration. Although three 
months of cryopreservation does not affect vein graft ar-
chitecture significantly, endothelial cells are damaged ir-
respective of the time of cryopreservation. Vein auto-
grafts promptly healed after one month of implantation 
at which time a viable endothelial cell lining was re-
stored from the host artery . Conversely, vein allografts, 
with and without seeded autologous endothelium, failed 
due to graft rejection . This study highlights that current 
methods of cryopreservation do not reduce antigenicity 
of venous allografts significantly. 
Key Words: Vein allograft, vein autograft , graft rejec-
tion , vein cryopreservation, scanning electron microsco-
py, transmission electron microscopy . 
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Introduction 
As compared with earlier days (Kunlin, 1949) , the 
improvements in cryo-techniques have resulted in signif-
icant tissue preservation following freezing and thawing 
of human saphenous vein allografts (Ligush et al., 
1991). Preliminary clinical trials (Fujitani et al., 1992; 
Harris et al . , 1993; Shah et al. , 1993 ; Walker et al., 
1993) have indicated the possibility of successfully using 
the cryopreserved venous allografts for lower extremity 
arterial reconstructions with the infected field and the 
unavailability of fresh autologous tissue being the major 
targets for their use. Consequently, tissue banking of 
venous allografts is turning into a major task for people 
involved in current surgical practice. Despite extensive 
experimental work in this field (for a review see, 
Faggioli et al., 1990; Greisler, 1991) , no result is yet 
available on the possibility of cryopreserving vein grafts 
efficiently for longer than 1 month . 
On the other hand, animal studies (Street et al., 
1988; Showalter et al. , 1989) suggest that a short time 
of cryopreservation does not drastically affect the integ-
rity of endothelial vein graft coverage. Functional re-
sults are contradictory. Findings suggesting a subtle en-
dothelial cell and smooth muscle cell dysfunction, i.e., 
decreased prostacyclin synthesis (Showalter et al., 1989) 
and lack of response to serotonin (Brockbank et al., 
1990), are at variance with those of a recent study which 
documents biochemical and metabolic characteristics of 
human venous allografts to be similar to those of fresh 
veins (Ligush, et al. , 1991). Finally, the pathological 
evaluation of explanted failed allografts have indicated 
the importance of residual vein antigenicity and graft 
atherosclerosis as additional problems (Greisler, 1991). 
In the following experiment, we investigated morpholog-
ically: a) the effect of long term cryopreservation (up to 
three months) on rabbit venous graft architecture and en-
dothelial cell residual integrity; b) the outcome of ve-
nous auto- and allografts following 1 month of implanta-
tion into rabbit carotid arteries; c) the potential host 
immunologic response to venous allograft implantation. 
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Materials and Methods 
Vein harvest and cryopreservation 
A total of 12 New Zealand white rabbits were 
used to harvest fresh veins. The animals were anesthe-
tized by intravenous sodium pentobarbital injection (30 
mg/kg) and maintained under halothane and oxygen by 
automatic ventilation. Jugular veins were excised with 
no-touch dissection and gently flushed with warm (37°C) 
Medium 199 (Gibco, Grand Island, NY, USA). Veins 
were then ligated at both extremities, cannulated and 
gently distended with freezing medium containing NCTC 
135 (Gibco), 20% fetal bovine serum (FBS; Gibco), 
17 .5 % dimethylsulfoxide (DMSO; Gibco) and 1 % non-
essential aminoacids (NEAA; Gibco). Each of the dis-
tended veins was placed into a cryogenic vial and frozen 
to -196°C at the controlled-rate of -5°C/sec. All steps 
were performed under sterile conditions. The specimens 
were then kept frozen at-196°C for 1, 2 and 3 months, 
respectively. 
At the end of the designated period, thawing was 
accomplished by fast rewarming of the cryogenic vial to 
37°C. After gentle flushing with Medium 199 , the veins 
were processed for ultrastructural investigation. 
Venous autograft and allograft implants 
After 3 months of cryopreservation , both vein au-
tografts (n = 3) and allografts (n = 3) were implanted 
in a group of six animals. The vein grafts were sutured 
with two end to side anastomoses in the rabbit carotid 
artery using 9-0 nylon sutures under microscopical con-
trol. The carotid artery between the two anastomoses 
was ligated at the end of procedure but not cut. Four 
weeks after surgery, each animal was anesthetized, the 
graft dissected free and the rabbit euthanatized. The 
animal care followed the "Principles of Laboratory Ani-
mal Care" and the "Guide for the Care and Use of Labo-
ratory Animals" (NIH Publication No 80-23 , revised 
1985). 
Controls were performed by implanting non-cryo-
preserved autologous veins for four weeks. 
Seeding with autologous endothelium 
Twelve animals were used to perform the follow-
ing experiment. To enzymatically harvest rabbit vein 
endothelial cells (RVECs), freshly excised jugular veins 
(n = 6) were incubated twice (20 minutes each step) 
with a 0.2 % collagenase dispase (Boheringer Mannheim 
Co., Indianapolis, IN, USA) solution. Following incu-
bation, the solution containing the RVECs was centri-
fuged at 300 g for 10 minutes at 4 °C, the supernatant 
discharged and the pellet suspended in 4 ml of endotheli-
al cell complete medium (ECCM) [Medium 199 contain-
ing 20% FBS, 100 IU/ml heparin (Organon, Inc.), 10 
µg/ml endothelial cell derived growth factor (Boheringer 
Mannheim Co.), 1 % vitamins (Gibco), 1 % NEAA, 1 % 
sodium pyruvate (Gibco), 0.1 % PSN (penicillin, strepto-
mycin, neomycin; Gibco) , and 0.05 % gentamicin 
(Gibco)]. The RVECs were then plated into T25 flask 
and incubated at 37°C with 5 % C02 . After 24 hours, 
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the cells were washed three times with PBS and refed 
with fresh ECCM. The medium was changed three 
times a week. When 90 % confluent, the cultures were 
trypsinized and rep lated at a 1: 6 ratio. Cells at the first 
or second passage were used to seed the vein grafts. 
RVECs identity was confirmed by the typical cobble-
stone appearance, with positive immunofluorescent stain-
ing for Factor VIII RA and negative actin staining. 
Six animals were used as vein allograft donors. 
Following excision, the jugular veins were de-endothe-
Iialized with a collagenase dispase solution and cryopre-
served for three months. At the time of the seeding ex-
periment, the vein allografts were thawed, vigorously 
and repeatedly rinsed with warm Medium 199 and 
seeded with aprroximately 2 x 106 autologous endotheli -
al cells per cm surface area. Each vein was then placed 
horizontally into a sterile tube with warm media, and in -
cubated at 37 °C with continuous rotation (1 rpm). After 
2 hours, the veins were removed from the sterile tube 
and implanted into the carotid artery of the rabbit which 
was previously used as source of endothelium. As a re-
sult, six rabbits in this group received a venous allograft 
seeded with autologous endothelial cells. Explants were 
performed between 4 days and 2 weeks. 
Controls were included to verify that the auto-
logous RVECs effectively adhered and spread onto the 
venous allografts. 
Transmission and scanning electron microscopy 
Representative samples from each experimental 
step were processed for transmission electron microsco-
py (TEM) and scanning electron microscopy (SEM). 
Each of the explanted venous grafts was cannulated, per-
fused under physiologic pressure (100 mm Hg) with 
warmed (37°C) Krebs-Henzleit saline solution (Sigma, 
St. Louis, MO, USA) and fixed with cacodylate-buffered 
glutaraldehyde in-situ. Subsequently , the specimens 
were fixed with glutaraldehyde for 2 hours, opened 
along their ventral surface, and cut into serial strips. 
After 1 hour of 1 % osmium tetroxide post-fixation, the 
samples were repeatedly washed in distilled water and 
dehydrated in a series of graded alcohols. Samples for 
TEM were embedded in epoxy resin. Thin sections were 
counterstained with uranyl acetate and lead citrate and 
observed in a Philips 400T transmission electron micro-
scope. Samples for SEM were critical point dried, sput-
ter-coated with 10 nm of gold and viewed in a Philips 
505 scanning electron microscope. 
Results 
Ultrastructure of cryopreserved vein grafts 
Following 1, 2 and 3 months of cryopreservation, 
no significant ultrastructural difference was found among 
rabbit vein grafts. 
By SEM, the vein graft surface was corrugated 
and partially covered by endothelial cells (Fig. 1). Foci 
of endothelial cell shedding associated with surface bleb-
bing and loss of intercellular contacts were seen. 
Ultrastructure of vein allografts 
By TEM, most of the endothelial cells showed 
pyknotic nuclei and cytoplasmic vacuoles (Fig. 2). The 
basal lamina was present. The elastic lamina showed a 
slight dissociation of elastotubules from the elastic 
moieties. Smooth muscle cells were generally unre-
markable except for variable lysis of myofilaments and 
cytoplasmic vacuolization (Fig. 3). 
Ultrastructure of autologous venous explants 
After 1 month of implantation, the 3-month cryo-
preserved vein autografts as well as the non cryopre-
served autografts (control) were patent and showed iden-
tical ultrastructural findings . 
By SEM, the cryopreserved autografts were con-
tinuously lined with flat endothelium (Fig. 4). The en-
dothelial cells were orderly aligned along the direction 
of the blood flow. Neither platelets nor fibrin were ob-
served. Leukocyte adherence was unremarkable. 
TEM of endothelium showed nuclei with finely 
dispersed chromatin and an occasional nucleolus (Fig . 
5). The cytoplasm contained cisternae of rough endo-
plasmic reticulum, mitochondria and abundant intermedi-
ate filaments. Stress fibers were found in endothelial 
cells lining the perianastomotic regions of the graft. 
Tight junctions were present. Scant leukocytes were ob-
served in the subendothelial space. The elastic lamina 
was continuous . In the media, the elastic fibers in -
creased throughout and focally condensed into small 
laminae. Many of the smooth muscle cells had dilated 
cisternae of rough endoplasmic reticulum containing 
moderately-dense synthesized material (Fig. 6). 
Ultrastructure of vein allograft explants 
After 1 month of implantation , only one of the 3 
months cryopreserved vein allografts was still patent 
(patency rate 12.6%). The other explants were throm -
bosed and transformed into fibrotic conduits. 
SEM of the patent allograft showed an endothe-
lialized graft surface with marked leukocyte adherence 
(Fig. 7). The surface inflammatory infiltrate, starting a 
few mm from the anastomotic sites, was homogeneously 
distributed along the length of the graft. Many leuko-
cytes were observed while migrating through evident in-
terendothelial gaps, into the subendothelial space. Re-
traction of the endothelium was noticed especially in the 
mid-portion of the graft (Fig. 8). 
By TEM, endothelial cells had convoluted nuclei 
with finely dispersed chromatin and abundant cytoplasm. 
Apart from the usual assortment of organelles, the cyto-
plasm contained a number of ribosomes, polyribosomes, 
and small profiles of rough endoplasmic reticulum. 
Weibel-Palade bodies were also found. The subendothe-
lial space was occupied by small and large, 'blast-like' , 
lymphocytes, monocyte/ macrophages as well as mi-
grated smooth muscle cells (Fig . 9). These latter cells 
had a few peripheral contractile filaments and numerous 
cisternae of rough endoplasmic reticulum. The elastic 
laminae were fragmented; in the media, lymphocytes 
were associated with smooth muscle cells having a syn-
thetic appearance, as well as fibroblasts (Fig. 10). The 
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adventitia contained a marked perivascular infiltrate of 
lymphocytes, plasma cells, monocyte/macrophages and 
neutrophils. 
Ultrastructure of seeded vein allograft explants 
Prior to implantation, controls showed a discon-
tinuous crowding of rounded endothelial cells on the sur-
face of the vein allograft (Fig. 11). Some endothelial 
cells spread over the graft surface (Fig. 12); filopodial 
contacts were observed . 
After implantation, five of the six vein grafts 
thrombosed within a short time (four days to two 
weeks). In three cases , the thrombus was organized 
within a fibrotic vein. Technical defects were ruled out. 
One vein graft was patent with no gross evidence of 
thrombus formation (patency rate 12.6%). 
By SEM , the patent allograft was de-endothe-
lialized. The surface showed a fibrin-mesh with acti -
vated platelets and erythrocytes (Fig. 13). Micro-
thrombi were also present. 
By TEM, no endothelial celis could be recog-
nized. The inner elastic lamina was interrupted and had 
a sieve-like appearance (Fig. 14). There was necrosis of 
the media with residual smooth muscle cells having 
pyknotic nuclei and degenerated cytoplasms (Fig. 15). 
Cell debris and neutrophilic infiltration were common 
findings (Fig. 16). Neutrophils were also observed fixed 
in a state of granule exocytosis. 
On the contrary, TEM of the thrombosed allo-
grafts showed a fibrotic media containing fibroblasts and 
scant inflammatory cells. Smooth muscle cells were 
virtually absent. 
Discussion 
In this study, we first evaluated the ultrastructure 
of the rabbit vein tissue after 1, 2 and 3 months of cryo-
preservation, respectively. Basically, no significant dif-
ference was found within the investigated specimens. 
Consequently , an adverse effect of storage time (up to 3 
months) and procedures (storage under liquid nitrogen at 
-196 ° C) on vein graft architecture was ruled out. This 
means that tissue banking of cryopreserved vein grafts 
is feasible within a reasonably short period of time. 
All the specimens showed marked endothelial cell dam-
age including, cell shedding, nuclear pyknosis, and cyto-
plasmic vacuolization, along with good preservation of 
the medial components, i.e., smooth muscle cells and 
elastic tissue. Unexpectedly, the use of improved tech-
niques for tissue cryopreservation, such as, delicate 
procedures of tissue handling, vein irrigation with warm 
(37°C) solutions, the use of DMSO as a cryoprotectant 
(Barner et al., 1966; Boren et al., 1977; L'Italien et al., 
1979; Sitzmann et al., 1984), rapid freezing (-5°C/sec), 
and fast thawing, did not prevent damage to the venous 
endothelial surface at all. This finding is at variance 
with previous studies (Dent et al., 1974; Weber et al., 
1976; Ladin et al., 1982; Lindanauer et al., 1982; Street 
et al., 1988; Brockbank et al., 1990) which found mor-
phologically intact endothelium after vein storage at low 
G. Pasquinelli et al. 
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Ultrastructure of vein allografts 
Figure 1. Three month cryopreserved vein graft showing the endothelial cell lining. SEM. Bar = 10 µm. 
Figure 2. Three month cryopreserved vein graft. The endothelial cells show surface blebbing (large arrowhead) and 
pyknotic nuclei. A slight dissociation of the elastotubules is also observed (small arrowheads). TEM . Bar = 1 µm . 
Figure 3. Three month cryopreserved vein graft. Smooth muscle cells are unremarkable. TEM . Bar = 1 µm. 
Figure 4. Cryopreserved autologous vein graft. Following one month of implantation , the graft surface is completely 
lined with a flat endothelium. SEM. Bar = 10 µm . 
Figure 5. Cryopreserved autologous vein graft. One month of implantation. By TEM , the endothelial cells show oval 
nuclei with finely dispersed chromatin . The cytoplasm contains a few profiles of rough endoplasmic reticulum , mito-
chondria and intermediate filaments . TEM. Bar = 1 µm . 
Figure 6. Cryopreserved autologous vein graft. One month of implantation. The smooth muscle cells show abundant 
rough endoplasmic reticulum; some cisternae are dilated and contain moderately-dense synthesized material 
(arrowheads). TEM. Bar = 10 µm. 
Figure 7. Cryopreserved allovein graft. Following one month of implantation , SEM shows a continuous endothelium 
with a marked leukocyte adherence. SEM. Bar = 10 µm. 
Figure 8. Cryopreserved allovein graft. One month of implantation. Retraction of endothelial cells (arrowheads) as 
observed in the mid-portion of the graft. SEM. Bar = 10 µm . 
Figure 9. Cryopreserved allovein graft. One month of implantation. TEM of the subendothelial space shows 
lymphocytes (ly) , monocytes (mo), and modified smooth muscle cells (arrows). TEM . Bar = 5 µm. 
Figure 10. Cryopreserved allovein graft. One month of implantation . Lymphocytes (ly), plasma cells (pc), and 
smooth muscle cells with a synthetic appearance are observed in the media. TEM. Bar = 1 µm. 
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Ultrastructure of vein allografts 
Figure 11. Allovein graft seeded with autologous endo-
thelium. Prior to implantation, TEM shows rounded en-
dothelial cells on the graft surface. TEM. Bar = 5 µm. 
Figure 12. Allovein graft seeded with autologous endo-
thelium. SEM shows some spread endothelial cells with 
numerous filopodial projections. Note that subendothe-
lial matrix is exposed at different sites (arrowheads). 
SEM . Bar = 2 µm. 
Figure 13. Allovein graft seeded with autologous endo-
thelium. Following four days of implantation, the graft 
surface is covered with fibrin, dendritic (arrowheads) 
and fully spread (arrows) platelets, as well as erythro-
cytes . SEM. Bar = 5 µm. 
Figure 14. Allovein graft seeded with autologous endo-
thelium. The four day explant shows frayed elastic la-
mellae with a sieve-like appearance. Elastotubules (ar-
rowheads) and lipid droplets are also evident. TEM. 
Bar = 0.5 µm. 
Figure 15. Allovein graft seeded with autologous endo-
thelit:m. After four days of implantation, TEM shows 
necrosis of smooth muscle cells (arrowheads). TEM. 
Bar = 1 µm. 
Figure 16. Allovein graft seeded with autologous endo-
theli m. Four days after implantation. A neutrophil is 
observed in correspondence with cell debris and rem-
nants of elastic tissue (arrowheads). TEM. Bar = 1 
µm. 
temperatures in the presence of a cryoprotectant agent 
(ammonium acetate, glycerol, and DMSO). In accord-
ance with our results, disruption of the endothelial layer 
was ultrastructurally demonstrated in human specimens 
by Ligush et al. (1991). We further documented this is-
sue indirectly by evidencing a failure in culturing endo-
thelic.l cells from analogous rabbit cryopreserved speci-
mens before implantation (Faggioli et al., 1993). Thus, 
our iew is that current methods of cryostabilization do 
not maintain endothelial cell integrity effectively. 
However, from our results, the significance of 
preserving an intact endothelium remains questionable 
for a least two reasons. First, four weeks after implan-
tation, all the cryopreserved vein autografts behaved like 
fresh autografts. They were patent and completely endo-
thelialized with early features of media arterialization. 
Since endothelium injured by cryopreservation is ex-
tremely susceptible to sloughing when exposed to the ar-
terial flow (Elmore et al., 1991; Faggioli et al., 1993), 
it car. be supposed that a reendothelialization takes place 
in cryopreserved rabbit vein autografts, the source of the 
neo-endothelium being the host arterial tissue. Second, 
unlike previous statements (Schwartz et al., 1967; Tice 
and Zerbino, 1972; Dent et al., 1974; Axthelm et al., 
1979; L'Italien et al., 1979; Malone et al., 1980; Theide 
et al ., 1981; Ladin et al., 1982; Showalter et al., 1989; 
Broc:(bank et al., 1990; Fujitani et al., 1992), we feel 
that ~ryopreservation does not significantly reduce the 
antigenicity of venous allografts. 
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Additionally, the presence of residual endothelium 
on vein allografts can be deleterious rather than benefi-
cial since injured endothelium can drastically trigger im-
munological reactions leading to graft failure. Further, 
they can determine production of procoagulant factors, 
such as thromboplastin and factor V, although this issue 
has not been yet investigated in cryopreserved veins. 
Additionally, Elmore et al. (1991) showed that the endo-
thelium of cryopreserved veins has more vasoconstric-
~ive properties than the fresh endothelium. Accordingly, 
rn the present study, all but one of the cryopreserved 
vein allografts were thrombosed and fibrosed after one 
month of implantation. 
Furthermore, the ultrastructure of the still patent 
allograft showed features of acute graft rejection. These 
latter allografts included a remarkable mixed inflamma-
tory infiltrate mainly affecting the intima and adventitia. 
In addition to lymphocytes, which are probably responsi-
ble for initiating immune-mediated graft damage, vary-
ing numbers of monocytes, plasma cells and neutrophils 
were also seen. 'Activated' lymphoid cells with 'blast-
like' features were also present. Interestingly, the endo-
thelial lining, presumed to be autologous in nature, was 
spared; whereas, the media featured foci of inflammato-
ry cells, modified smooth muscle cells, fibroblasts, and 
degenerated elastic tissue. 
These findings further extend the issue of venous 
allograft antigenicity. Although most of previous studies 
have concentrated upon endothelial cell antigenicity, 
smooth muscle cells and extracellular matrix compo-
nents, such as the elastic tissue, can play an additional 
role in the mechanism of vein graft rejection. Support 
of this hypothesis is the finding of smooth muscle cell 
expression of molecules (class I and II major histocom-
patibility complex antigens as well as vascular cell adhe-
sion molecule-I, VCAM-1) which are known to be im-
portant in directing immune-mediated responses (Munro 
and Cotran, 1988; Briscoe et al., 1992). On the other 
hand, elastic tissue can be potentially immunogenic since 
elastin-derived peptides were found implicated in the 
pathogenesis of human inflammatory abdominal aneu-
rysms (Gargiulo et al., 1993). 
Further evidence of this issue comes from the ob-
servation of explants of vein allografts seeded with auto-
logous endothelium. All but one of these grafts throm-
bosed within a very short time (from four days to two 
weeks). This early failure was believed to be a conse-
quence of incomplete endothelial cell seeding. Ultra-
structural examination of the seeded vein grafts before 
implantation showed many areas lacking any cell cover-
age with highly thrombogenic subendothelial matrix 
components exposed to the blood flow. Of interest, 
TEM of a four day patent explant showed neutrophilic 
infiltration and necrosis of the media. The presence of 
neutrophils, which are considered highly specific for the 
diagnosis of rejection in other tissues, is particularly 
important since they are suspected to augment immuno-
logical damage to target structures by delivering lytic 
enzymes as well as metabolic products, e.g., hydrogen 
G. Pasquinelli et al. 
peroxide, into the matrix (Adams et al., 1990). Neutro-
philic recruitment followed by disruption of media com-
ponents can therefore be responsible for the fibrotic 
evolution of the older failed explants. 
The present results, which are at variance with 
most of the previous work on this subject, need obvious 
confirmation in other experimental settings, including 
the ongoing clinical trials as well. However, cryo-tech-
nologies for preserving vein tissue and, most important-
ly, the immunological characteristics of the cryopre-
served vein allografts with and without endothelial cells 
should be more extensively investigated. In our opinion, 
future issues to be explored in order to resolve the im-
munological problems would be: 
a) Improved seeding with autologous endotheli-
um. Our preliminary results show complete endothelial-
ization after 22 hours of cell incubation (results not 
shown). 
b) Human leukocyte antigen (HLA) matching in-
stead of the actually recommended ABO matching whose 
clinical efficacy is questionable in light of the results 
obtained in the clinical settings (Harris et al., I993; 
Shah et al., I993; Walker et al., I993). 
c) Graft treatment with antibodies directed to 
integrins, such as, the intracellular adhesion molecule-I 
(ICAM-I) and VCAM-I, which mediate adhesion of in-
flammatory cells to endothelial cells as well as to 
mesenchymal cytotypes. 
d) Administration of low-dose, short term effec-
tive immunosuppressive drugs according to Augelli et al. 
(1991) who have recently found that cyclosporin A im-
proves the patency of either fresh or cryopreserved allo-
grafts in the dog model. 
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Discussion with Reviewers 
K.A. Robinson: Perhaps the most interesting finding is 
the disparity between your results and those of previous 
investigators with regard to both long-term patency and 
immunologic rejection of cryopreserved homografts. 
Are methodologic differences to blame? 
Authors: Early studies on this subject showed better 
patencies in cryopreserved allografts when compared to 
fresh controls. However, cryopreservation techniques in 
these ·studies were somehow "rudimental" and significant 
cell damage probably occurred during the freezing-thaw-
ing cycle. We believe that the cell loss may have de-
creased the overall antigenicity of the venous wall. In 
more recent studies , improved freezing techniques al-
lowed a better preservation of all the wall components; 
therefore, the patencies obtained were comparable to 
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those of fresh allografts, which are notoriously poor. 
Some recent studies showed that acceptable patencies are 
achieved in cryopreserved venous allografts only with 
concomitant immunosuppressive and an ti platelet therapy 
[Augelli et al., 1991; Miller VM, Bergman RT, 
Gloviczki P, Brockbank KGM. (1993). Cryopreserved 
venous allografts: effects of immunosuppression and 
antiplatelet therapy on patency and function. J Vase Surg 
18: 216-226]. In this respect our study further supports 
these data. 
K.A. Robinson: Please comment further on the ration-
ale for autologous endothelial cell (EC) seeding of the 
cryopreserved allografts. Presumably one reason is to 
enhance compatibility in the host ; yet your results indi-
cate no difference between seeded versus unseeded cryo-
preserved allografts in terms of immunologic/inflamma-
tory sequelae. 
Authors: The rationale for autologous EC seeding was 
exactly to reduce immunoreaction by increasing compati-
bility . Previous studies showed that endothelium is the 
major immunological target in graft rejection (Greisler, 
1991). Our results do not support this view. Smooth 
muscle cells and other components of the venous wall 
seem to be responsible for immunoreaction, despite the 
fact that some authors reported better patencies in de-en-
dothelialized venous allografts if compared with intact 
alloveins [Galumbeck MA, Sanfilippo FP , Hagen PO, 
Seaber AV, Urbaniak JR. (1987). Inhibition of vessel 
allograft rejection by endothelial removal. Ann Surg 
206: 757-764]. 
K.A. Robinson: How does the ultrastructure (particu-
larly of the EC) of the cryopreserved specimens compare 
to freshly harvested veins? 
Authors: Basically, we found that cryopreservation 
significantly affected the endothelial cell viability. 
Ultrastructurally, a variable, but constant, EC loss was 
appreciated in the examined samples. Residual endothe-
lium showed nuclear changes, including chromatin 
clumps and pyknosis, as well as features of cytoplasmic 
damage, such as mitochondrial swelling and vacuoliza-
tion. Surface blebbing was also prominent. The EC 
suboptimal morphological preservation is also in agree-
ment with the failure in culturing EC from analogous 
cryopreserved specimens (Faggioli et al., 1993). How-
ever, it should be also mentioned that smooth muscle 
cells and matrix components, which showed an almost 
unremarkable ultrastructural morphology, were less af-
fected by the freezing-thawing cycle. 
M.F. Sigot-Luizard: You said, and I think probably 
rightly, that "from our results, the significance of pre-
serving an intact endothelium remains questionable". 
Moreover, you supposed that the reendothelialization of 
the autograft vein is provided by the host arterial tissue. 
Did you perform some experiments to be able to confirm 
this hypothesis? 
G. Pasquinelli et al. 
Authors: Yes, we did (Faggioli et al., 1993). First, we 
studied two-hour explants of cryopreserved rabbit vein 
autografts and found that, at this time, the EC were 
completely lost from the venous surface, the surface be-
ing lined with a mesh of fibrin and fully spread platelets 
only. Second, we found that analogous one month ex-
plants showed a completely endothelialized graft surface. 
Consequently, we supposed that reendothelialization was 
mostly provided by the host arterial tissue. 
R.M. Albrecht: The findings regarding t e antigenicity 
of remaining EC and of the other vessel components are 
of considerable importance. While the non-seeded grafts 
were first observed at one month , the seeded grafts were 
observed as early as 4 days. Most of these apparently 
showed evidence of acute rejection. Was this simply a 
general inflammatory response to the damaged tissue or 
have the animals somehow been previously sensitized to 
the foreign antigen so that this very rapid response oc-
curs? Is there any data which indicates the unseeded 
alloveins also shows this rejection response by the 4 day 
time point? 
Authors: We suspect that the pathologic picture we ob-
served in the seeded vein allografts may correspond to 
an early stage of the otherwise typical features of acute 
rejection found in the unseeded alloveins. This finding 
is not surprising because rabbit jugular veins from dif-
ferent inbred strains were employed as vein allografts. 
Under these circumstances, an acute graft rejection is 
reasonably expected within a few days or weeks depend-
ing on the number and immunogenic strength of the anti-
gens present in the graft but absent in the recipient. 
Alternatively, one can speculate that an unexpected form 
of hyperacute graft rejection may have occurred in these 
specimens. As you suggest, an hyperacute rejection is 
generally associated with the presence of preformed cir-
culating antibodies in the recipient directed against 
donor HLA or ABO antigens. However, this does not 
seem to be so in the present case. Further, it should be 
also mentioned that, at least in humans, not all patients 
with circulating antidonor HLA or ABO antigens develop 
hyperacute rejection; there are also occasional cases that 
demonstrate no detectable antidonor antobodies in recipi-
ent serum or allograft eluates, even if clinically and 
pathologically characterized as hyperacute rejection 
[Sanfilippo FP. (1990). Renal Transplantation. In: The 
Pathology of Organ Transplantation. Sale GE (ed .). But-
terworths. pp. 51-101). Regarding to your last question, 
at the present , we have no data on the unseeded allo-
veins. 
R.M. Albrecht: The actual rates of freezing and thaw-
ing of the cells and tissues often vary over time, i.e., are 
not linear, due to the latent heat of fusion, conductivity, 
exposed surface area, etc. Thus, even if the cooling de-
vice tools a block of metal at a certain rate it is still im-
portant to know the actual cooling curve of a biological 
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specimen in the cooling device. Are the actual freezing 
and thawing rate curves known (for example, measured 
by thermocouples inserted in the specimen)? Is ice 
crystal damage or formation of intracellular ice seen 
with this cryoprotectant and with these rates of cooling? 
Could extensive damage produced by the freezing and 
thawing technique effectively mask any minor damage 
related to the length of storage? 
Authors: Thermoelectric couples were not used in our 
model. Although previous studies stated that DMSO, at 
the concentration herein employed, efficaciously prevent 
the formation of ice crystals intracellularly , we believe 
that no conclusive data exist on this issue. Strictly 
speaking, cryoprotection with DMSO means the addition 
of solutes and the reduction of intracellular free water to 
living cells in order to increase survival rates after 
freezing and thawing. Many living cells, subjected to 
slow freezing rates when suitably cryoprotected survive 
freezing and thawing as a result of the slow removal of 
water from cells and the growth of extracellular ice. 
However, survival of a living cell following the freez-
ing-thawing cycle does not mean suitable preservation of 
the original fine structure of that cell. Thus, we believe 
that ice crystals do occur intracellularly. However, 
turning to the preservation of vein components and in 
particular of EC , we do not know how much EC damage 
is proportionally caused by freezing-thawing per se, or 
by DMSO cryoprotection, which is also potentially dele-
terious. In this respect, the resulting cell damage can 
obviously mask any additional, even though minimal, 
damage caused by storage conditions. 
R.M. Albrecht: Were any studies performed in vitro or 
in vivo to see if the seeded autologous EC remained in 
place during pulsatile flow at arterial pressures? 
Authors: We examined a couple of two-hour explants 
and we did not find any endothelial cell on the graft sur-
face . However, as discussed in the paper, at that time 
we did not succeed in achieving a continuous and flat EC 
monolayer on the graft surface. Subsequently, we exam-
ined the 22-hour seeded alloveins and found that approx-
imately 75 % of the original EC were still present after 
2 hours of implantation. 
R.M. Albrecht: Why is bovine serum, rather than auto-
logous rabbit serum, used in the freezing media; might 
this not actually increase the antigenicity of the vessels 
if bovine molecular species bind in the subendothelium? 
Authors: This comment is very appropriate and we 
thank the reviewer for focusing o'n this subject. We 
chose bovine serum rather than rabbit serum because this 
is the technique used in most clinical studies and we 
elected to keep all variables as close as possible to the 
clinical settings . Moreover, our serum is heat-inacti-
vated and should not interfere significantly, even if still 
present on the venous surface after careful washing, with 
immunological reactions. 
